title: Successful management of bevacizumab-associated surgical bleeding with an Ankaferd blood stopper.
authors.forename: Nuriye
authors.initials: N
authors.lastname: Ozdemir
authors.forename: Sercan
authors.initials: S
authors.lastname: Aksoy
authors.forename: Tülay
authors.initials: T
authors.lastname: Eren
authors.forename: Dogan
authors.initials: D
authors.lastname: Uncu
authors.forename: M Bülent
authors.initials: MB
authors.lastname: Akinci
authors.forename: Mehmet Erdem
authors.initials: ME
authors.lastname: Alaguney
authors.forename: Nurullah
authors.initials: N
authors.lastname: Zengin
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D000068258:Bevacizumab; D006470:Hemorrhage / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010936:Plant Extracts / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D010936:Plant Extracts; C539751:ankaferd blood stopper; D000068258:Bevacizumab